Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-044813
Filing Date
2024-11-12
Accepted
2024-11-12 16:55:37
Documents
63
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 795493
2 ex31-1.htm EX-31.1 11642
3 ex31-2.htm EX-31.2 11630
4 ex32-1.htm EX-32.1 7186
5 ex32-2.htm EX-32.2 7337
  Complete submission text file 0001493152-24-044813.txt   4819555

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE iztc-20240930.xsd EX-101.SCH 39247
7 XBRL CALCULATION FILE iztc-20240930_cal.xml EX-101.CAL 48264
8 XBRL DEFINITION FILE iztc-20240930_def.xml EX-101.DEF 195072
9 XBRL LABEL FILE iztc-20240930_lab.xml EX-101.LAB 332628
10 XBRL PRESENTATION FILE iztc-20240930_pre.xml EX-101.PRE 273592
65 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 684201
Mailing Address 750 ROYAL OAKS DR MONROVIA CA 91016
Business Address 750 ROYAL OAKS DR MONROVIA CA 91016 (626) - 415 - 1488
Invizyne Technologies Inc (Filer) CIK: 0002010788 (see all company filings)

EIN.: 834550057 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42204 | Film No.: 241449472
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)